Drug Trial Radar · NCT00503698
The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis
Last checked: Nov 19, 2026Latest source record: Mar 7, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
712
Actual
Start
Jul 2007
Primary completion
Dec 2008
Study completion Dec 2008
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Jul 19, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is conducted in Africa, Asia, Europe, North and South America and Oceania. The aim of the trial is to evaluate the effect of somatropin (human growth hormone) on survival (primary end-point; "time to death" and health related quality of life in adult patients on chronic haemodialysis.
Conditions
- Chronic Kidney Disease
- End-Stage Renal Disease
Interventions
somatropinDrug
20 mcg/kg/day, injected s.c. (under the skin)
placeboDrug
Placebo injected s.c (under the skin)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mortality - Time to All-cause DeathTime frame: week 0, trial termination
Locations
381 sites in 21 countries. Site status is shown where the registry gives one.
Novo Nordisk Investigational Site
Alexander City, Alabama
Novo Nordisk Investigational Site
Birmingham, Alabama
Novo Nordisk Investigational Site
Madison, Alabama
Novo Nordisk Investigational Site
Mobile, Alabama
Novo Nordisk Investigational Site
Mobile, Alabama
Novo Nordisk Investigational Site
Montgomery, Alabama
Novo Nordisk Investigational Site
Glendale, Arizona
Novo Nordisk Investigational Site
Phoenix, Arizona
Novo Nordisk Investigational Site
Tempe, Arizona
Novo Nordisk Investigational Site
Tucson, Arizona
Novo Nordisk Investigational Site
Tuscon, Arizona
Novo Nordisk Investigational Site
El Dorado, Arkansas
Novo Nordisk Investigational Site
Fort Smith, Arkansas
Novo Nordisk Investigational Site
Hot Springs, Arkansas
Novo Nordisk Investigational Site
Little Rock, Arkansas
Novo Nordisk Investigational Site
McGehee, Arkansas
Novo Nordisk Investigational Site
Paragould, Arkansas
Novo Nordisk Investigational Site
Pine Bluff, Arkansas
Novo Nordisk Investigational Site
Beverly Hills, California
Novo Nordisk Investigational Site
Chula Vista, California
Novo Nordisk Investigational Site
Covina, California
Novo Nordisk Investigational Site
Escondido, California
Novo Nordisk Investigational Site
Glendale, California
Novo Nordisk Investigational Site
La Mesa, California
Novo Nordisk Investigational Site
Lakewood, California
Novo Nordisk Investigational Site
Long Beach, California
Novo Nordisk Investigational Site
Los Alamitos, California
Novo Nordisk Investigational Site
Los Angeles, California
Novo Nordisk Investigational Site
Los Angeles, California
Novo Nordisk Investigational Site
Los Angeles, California
Novo Nordisk Investigational Site
Lynwood, California
Novo Nordisk Investigational Site
Merced, California
Novo Nordisk Investigational Site
Mission Hills, California
Novo Nordisk Investigational Site
Monterey Park, California
Novo Nordisk Investigational Site
Mountain View, California
Novo Nordisk Investigational Site
Pasadena, California
Novo Nordisk Investigational Site
Porterville, California
Novo Nordisk Investigational Site
Riverside, California
Novo Nordisk Investigational Site
Sacramento, California
Novo Nordisk Investigational Site
Torrance, California
Showing 40 of 381 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.